The Innovation Exchange
Step into the spotlight. Leave with momentum.
This is your shot to stand in front of the people who can fund you, partner you, or pass! The Innovation Exchange puts early-stage biotech companies in front of the people who can actually move them forward. Capital, partners, and strategic attention, all in one room.
If you are building a company that needs funding, partnerships, or visibility to scale, this is your moment to show up with intent.
The Innovation Exchange is a curated, high-visibility pitch session embedded within the main agenda of Advanced Therapies Europe. Launched in 2025, this is where therapeutic developers step onto a main stage and pitch directly to investors, pharma, and dealmakers actively looking for what’s next in cell and gene therapy.
Qualification: Pre-seed to Series A therapeutic developers.
Six selected companies will pitch live to a room of senior decision-makers, alongside a panel of leading investors and pharma partners who are there to evaluate, challenge, and engage.
You present your company. Investors ask the questions that matter. The room is watching.
If you stand out, you leave with more than attention, you leave with momentum.
Finalists receive:
Want a preview of the ATE community?
See who was in the room this year and the organisations leading the way in advanced therapies.
Download the 2025 Attendee List
)
)
)
)
)
)
)
)
)
)
